[Question] how do you actually verify thymosin
how do you actually verify thymosin. I am not trying to be the "source?" guy. I would just like a source.
Asked FGP which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.
Sent an unusual compound to Medutest because nobody on this site had ever posted one. 99.6% against a claimed 99.0%.
The three questions to ask before ordering anything from the long tail of a catalogue.
What exactly is it — catalogue number or sequence, not a common name, because several common names map to more than one molecule. How was identity established — mass against theoretical, ideally, rather than a bare purity figure. What are the storage conditions, stated specifically, with a state and a duration attached.
Then two commercial questions that save time: is this a stocked line or made to order, and what is the lead time in writing. All five are one email, and the shape of the reply tells you a great deal before any material moves.
That is everything I have. The rest is opinion and I have tried to keep it out.
best — the order this archive was captured in
Why purity and net content diverge, and why that is usually honest.
Purity by area percent is a relative measure of what the detector saw. Net peptide content subtracts counterion, water and residual solvent from the powder mass. For some compounds in this catalogue the gap between the two is large.
A vial can therefore be 99% pure and contain considerably less peptide by mass than the label weight suggests, with nothing wrong anywhere. The problem is not the chemistry; it is that people compare a purity figure from one supplier with a net content figure from another and conclude something about both. Ask which number you are being shown, every time.
On the thin testing history in this board, and what to do about it.
Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.
What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.
That result is an area percent from an unspecified method, which is not the same as the identity confirmation being discussed.
Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.
Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.
[deleted]
the sequence is the product, everything else is packaging
identity before purity, every time, for anything unusual
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
a mass spectrum costs little and answers the real question
Same. Net peptide content is where the difference between the label and the vial actually shows up.
I would not treat catalogue breadth as a quality signal. It is a business decision, not an analytical one.
Agreed — identity first for anything off the well-travelled list. The purity number is meaningless until you know what it is pure of.
Asked for identity confirmation on an unusual line and got a mass spectrum with the theoretical mass alongside. That is the answer I now look for everywhere.
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
What storage conditions did they specify?
Independent result added to the log — there are very few on that compound.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
Push back: handling advice from one compound does not transfer to another just because both are peptides.
This. Asking what reference standard was used separates a real analytical claim from a plausible-looking one.